GLP-1 for Heart Health: What the Evidence Does and Doesn't Show (October 2026)

01 · Core answer

Is GLP-1 good for the heart?

GLP-1 medicines are widely discussed for heart health, but the answer is not the same for every product. Different medicines have been studied in different groups of people, and a result for one medicine does not automatically transfer to another. That is why a blanket line such as "GLP-1s protect your heart" is less useful than it sounds.

Mounjaro is a once-weekly injection that activates two gut-hormone receptors, GIP and GLP-1, and that helps regulate appetite, slow stomach emptying and improve the body's response to insulin.¹ In the UK it is licensed for weight management in adults and for type 2 diabetes.¹ Anything beyond that, such as reduced heart attack or stroke risk, belongs in a conversation with your own clinician.

If a headline cites a figure, check which medicine, which patients and which outcome it describes. Our related guides on whether Mounjaro helps heart health and whether it is good for your heart take the same careful approach.

02 · Your decision

What should you do next?

Start with your own situation. If you have no known heart condition and want weight-management treatment, the question is mainly whether you meet the licensed criteria. If you have heart disease, high blood pressure, or take heart medicines, tell the prescriber and your GP or cardiologist before you begin.

If treatment looks suitable, you can begin with a free online consultation reviewed by a GPhC-registered prescriber. Our Mounjaro pen starts with the 2.5mg dose at a standard price of £169.99 per month, and all six doses are in stock. Our weight loss clinic page explains the full process.

03 · Weight loss and your heart

Weight loss versus heart protection

Losing weight and protecting the heart are related goals, but they are not the same measurement. A medicine can reduce body weight without that being proven to change heart outcomes, and the reverse can also be true. Clinicians therefore look at the evidence for each outcome separately.

For weight, the Mounjaro trial evidence is clear. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, and individual results vary. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

That trial measured weight, not heart events. So the fair reading is that Mounjaro is a well-evidenced weight-management medicine. Whether that translates into a lower chance of a heart attack for you is something to discuss with a doctor who can see your blood pressure, cholesterol and family history. Our guide to Mounjaro and heart health goes into the practical side.

04 · Which GLP-1 for the heart

Which GLP-1 is best for heart health?

No single GLP-1 medicine is best for heart health; the prescriber or specialist decides what suits the person.

The medicines you will see discussed in the UK include tirzepatide (Mounjaro), semaglutide (Wegovy and Ozempic) and daily liraglutide. They are not interchangeable. Tirzepatide acts on both GIP and GLP-1 receptors, which distinguishes it from single-action medicines such as semaglutide.¹ Liraglutide is a daily injection, unlike once-weekly Mounjaro and Wegovy.

If heart protection is a main reason you are considering a GLP-1, that is a cardiology or diabetes-clinic decision rather than a pharmacy-shelf choice. Take these medicine names to your appointment and ask which has evidence for your situation. If weight management is the goal, you can compare our Wegovy pen and Mounjaro with the prescriber during your consultation.

05 · Existing heart conditions

If you already have a heart condition

Tell the prescriber about every heart diagnosis and medicine before treatment starts. This includes heart failure, previous heart attack or stroke, irregular rhythm, and blood pressure or cholesterol treatment. The prescriber can then decide whether the order is suitable, and unsuitable orders are refunded automatically.

First, Mounjaro can reduce absorption of oral contraceptives because stomach emptying slows, so ask about contraception if it applies to you.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ Second, if you take insulin or sulfonylureas, doses may need adjusting because of low blood sugar risk. It does not mean the medicines cannot be used together.

For specific situations, see our guides on taking a GLP-1 with heart failure and GLP-1 and heart palpitations. If you notice a new symptom after starting, speak to your prescriber and report it through the Yellow Card scheme.¹⁹

06 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

07 · NHS and other questions

NHS access, bones, coverage and headlines

Mounjaro is available on the NHS, but access is being phased in over several years.⁴ NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the primary-care rollout began in June 2025 with the highest-need groups first.⁶ Many people who meet the licensed criteria choose regulated private treatment rather than waiting.

US-style insurance coverage questions do not apply to a UK private prescription. For anything about bones or long-term effects, ask your prescriber.

Our broader guide to weight loss injections and heart health and the overview of GLP-1 and the heart are good next reads.